Search

everythinglearnresearchcommunity

for

Search:↓

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Fat cells help recruit healing cells and build skin structure during wound healing.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Piperine from black pepper can make hair less oily by blocking fat cell development in hair roots.

Nelfb is crucial for forming skin fat tissue by regulating genes needed for fat cell development.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Opophytum forskahlii seed oil may help with anti-aging and hair growth.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.